Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Main Authors: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Frontiers Media
2024
|
Títulos similares
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
por: Grace A. Borchert, et al.
Publicado: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
por: Grace A. Borchert, et al.
Publicado: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
por: Michelle E. McClements, et al.
Publicado: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
por: Borchert, GA, et al.
Publicado: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
por: Hoda Shamsnajafabadi, et al.
Publicado: (2023-08-01)